BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12761111)

  • 1. Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.
    Spyres LM; Daniel J; Hensley A; Qa'Dan M; Ortiz-Leduc W; Ballard JD
    Infect Immun; 2003 Jun; 71(6):3294-301. PubMed ID: 12761111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion.
    Spyres LM; Qa'Dan M; Meader A; Tomasek JJ; Howard EW; Ballard JD
    Infect Immun; 2001 Jan; 69(1):599-601. PubMed ID: 11119561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases.
    Schmidt M; Voss M; Thiel M; Bauer B; Grannass A; Tapp E; Cool RH; de Gunzburg J; von Eichel-Streiber C; Jakobs KH
    J Biol Chem; 1998 Mar; 273(13):7413-22. PubMed ID: 9516439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
    Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
    Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
    May M; Wang T; Müller M; Genth H
    Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate
    Larabee JL; Bland SJ; Hunt JJ; Ballard JD
    mBio; 2017 May; 8(3):. PubMed ID: 28512094
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells.
    Qa'Dan M; Ramsey M; Daniel J; Spyres LM; Safiejko-Mroczka B; Ortiz-Leduc W; Ballard JD
    Cell Microbiol; 2002 Jul; 4(7):425-34. PubMed ID: 12102688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B.
    Genth H; Schelle I; Just I
    Toxins (Basel); 2016 Apr; 8(4):109. PubMed ID: 27089365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
    Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
    Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
    Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
    Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
    Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination.
    Bland SJ; Larabee JL; Shadid TM; Lang ML; Ballard JD
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31138612
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional defects in
    Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
    J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of p38
    Schelle I; Bruening J; Buetepage M; Genth H
    Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28025502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-enhanced cytopathic effects of Clostridium sordellii lethal toxin.
    Qa'Dan M; Spyres LM; Ballard JD
    Infect Immun; 2001 Sep; 69(9):5487-93. PubMed ID: 11500421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
    Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
    PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
    Li S; Shi L; Yang Z; Feng H
    Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tip of the Four N-Terminal α-Helices of Clostridium sordellii Lethal Toxin Contains the Interaction Site with Membrane Phosphatidylserine Facilitating Small GTPases Glucosylation.
    Varela Chavez C; Haustant GM; Baron B; England P; Chenal A; Pauillac S; Blondel A; Popoff MR
    Toxins (Basel); 2016 Mar; 8(4):90. PubMed ID: 27023605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
    Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
    Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.